Clinical Trial Update: Evaluation Effectiveness and Safety of (cTACE or DEB-TACE + FOLFOX Regimen HAIC) Combined With Camrelizumab and Apatinib Mesylas in the Treatment of Advanced Hepatocellular Carcinoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the combination of cTACE or DEB-TACE plus FOLFOX-based hepatic arterial infusion chemotherapy with camrelizumab and apatinib…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Apatinib (apatinib)
• Camrelizumab (camrelizumab)
• DEB-TACE
• FOLFOX
• cTACE

Snippet

Sponsor: Peking University Cancer Hospital & Institute | Conditions: Hepatocellular Carcinoma | Phase 2 | Status: UNKNOWN